Organon & Co. financial data

Symbol
OGN on NYSE
Location
Jersey City, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 167% % 2.2%
Quick Ratio 52% % 9.2%
Debt-to-equity 1909% % -76%
Return On Equity 76% % -91%
Return On Assets 4% % -65%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 259,982,912 shares 0.95%
Common Stock, Shares, Outstanding 259,983,000 shares 0.95%
Entity Public Float $5,300,000,000 USD 0%
Common Stock, Value, Issued $3,000,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 259,975,000 shares 0.96%
Weighted Average Number of Shares Outstanding, Diluted 260,653,000 shares 0.34%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $6,301,000,000 USD -1.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $702,000,000 USD -10%
Income Tax Expense (Benefit) $201,000,000 USD
Net Income (Loss) Attributable to Parent $501,000,000 USD -61%
Earnings Per Share, Basic 1 USD/shares -62%
Earnings Per Share, Diluted 1 USD/shares -62%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $672,000,000 USD -12%
Accounts Receivable, after Allowance for Credit Loss, Current $1,484,000,000 USD -12%
Inventory, Net $1,488,000,000 USD 7.6%
Other Assets, Current $1,056,000,000 USD 14%
Assets, Current $4,700,000,000 USD -1.2%
Property, Plant and Equipment, Net $1,290,000,000 USD 7.1%
Operating Lease, Right-of-Use Asset $157,000,000 USD -9.2%
Goodwill $4,680,000,000 USD 1.7%
Assets $13,552,000,000 USD 6.3%
Accounts Payable, Current $1,074,000,000 USD -1.6%
Liabilities, Current $2,679,000,000 USD -4%
Deferred Income Tax Liabilities, Net $62,000,000 USD 11%
Operating Lease, Liability, Noncurrent $112,000,000 USD -10%
Other Liabilities, Noncurrent $1,122,000,000 USD 66%
Liabilities $12,646,000,000 USD 3.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $574,000,000 USD -0.52%
Retained Earnings (Accumulated Deficit) $1,318,000,000 USD 35%
Stockholders' Equity Attributable to Parent $906,000,000 USD 84%
Liabilities and Equity $13,552,000,000 USD 6.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $75,000,000 USD -1.3%
Net Cash Provided by (Used in) Financing Activities $75,000,000 USD -1.4%
Net Cash Provided by (Used in) Investing Activities $172,000,000 USD -79%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 259,983,000 shares 0.95%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $128,000,000 USD -8.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $672,000,000 USD -12%
Deferred Tax Assets, Valuation Allowance $261,000,000 USD -16%
Deferred Tax Assets, Gross $1,297,000,000 USD 11%
Operating Lease, Liability $156,000,000 USD -8.8%
Depreciation $34,000,000 USD 6.2%
Payments to Acquire Property, Plant, and Equipment $32,000,000 USD -30%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $498,000,000 USD -62%
Lessee, Operating Lease, Liability, to be Paid $177,000,000 USD -6.3%
Operating Lease, Liability, Current $44,000,000 USD -4.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two $34,000,000 USD -29%
Lessee, Operating Lease, Liability, to be Paid, Year One $49,000,000 USD -5.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) $17,000,000 USD -440%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $21,000,000 USD 17%
Lessee, Operating Lease, Liability, to be Paid, Year Three $28,000,000 USD -3.4%
Deferred Tax Assets, Operating Loss Carryforwards $224,000,000 USD 540%
Unrecognized Tax Benefits $121,000,000 USD 5.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four $18,000,000 USD 29%
Deferred Tax Assets, Net of Valuation Allowance $1,036,000,000 USD 20%
Share-based Payment Arrangement, Expense $96,000,000 USD -9.4%
Interest Expense $515,000,000 USD -0.39%